Researchers have discovered an antibody that may contribute to improved lung cancer outcomes. However, they face challenges in developing it into an effective treatment.
This finding offers hope for potential advancements in lung cancer management, but a lot of work lies ahead to translate this discovery into practical solutions for patients.
Original Source: The New York Times